News - Arthrocare Corp.
The Cavity SpineWand®, developed by ArthroCare (Nasdaq: ARTC), a multi-business medical device company, has been successfully used in treating patients suffering from spine tumors -- clinically known as spinal metastases.
ArthroCare Corp. (Nasdaq:ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced that it has acquired DiscoCare, Inc., a third-party billing and reimbursement service provider, for $25 million in cash plus potential future milestone payments.
ArthroCare Corp. (Nasdaq:ARTC), a leader in developing state-of-the-art, minimally invasive surgical products today announced that its Board of Directors has approved the repurchase of up to $75 million of its outstanding common stock.